Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BIOMES logo — Health prevention based on genomics: because well-being is e...

BIOMES

Health prevention based on genomics: because well-being is encoded in our DNA.

Founded 2017 Germany Wildau, Germany 37 employees Unknown Total: $4.00M

General Information

Company Name BIOMES
Founded Year 2017
Location Germany Wildau, Germany +2
Founders / Decision Makers
Team member
Employees 37
Funding Stage Unknown
Social

Get notified when BIOMES moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BIOMES

BIOMES is a biotech startup focusing on health prevention through genomic analysis. Founded in 2017 and headquartered in Germany, the company offers scientific self-testing kits to understand the human microbiome. BIOMES uses high-throughput DNA sequencing, machine learning, and community engagement to analyze the microbiome and provide evidence-based recommendations for individuals to restore their gut balance naturally. The company's flagship product, INTEST.pro, is a DNA-based gut microbiome analysis that offers personalized health insights and actionable recommendations. Through a process that involves sending a stool sample to their lab in Wildau, Germany, BIOMES extracts and analyzes the DNA to empower users to make informed decisions about their well-being. With a focus on Big Data, Biotechnology, Health Care, Health and Wellness, Life Sciences, Nutrition, Clean Energy, and Lifestyle, BIOMES has garnered the attention of investors. In its Corporate Round investment at 20 November 2024, the company secured funding from Keiyo Gas, showcasing the investor interest in the promising capabilities of BIOMES in the genomics and health sector.

Taxonomy: Genomics, Microbiome Analysis, Health Tech, DNA Sequencing, Personalized Medicine, Scientific Research, Health Prevention, Wellness, Gut Health, Biotech Startups, Digital Healthcare, Community Health

Services & Products

Microbiome analysis and personalized nutrition recommendations

Target Customers

Individuals seeking personalized health insights and nutritional guidance

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC •••••• 1 •••• •••• 01 Nov 2024
Seed •••••• - 01 Dec 2020
Early VC •••••• 1
Investor
01 Feb 2020
Spinout •••••• 1 •••• •••• 01 Nov 2017

BIOMES Alternatives & Competitors

View All Alternatives
BIOMES vs
Realize Therapeutics
Realize Therapeutics United States

Millions more healthy, happy lives.

5 employees
Biotechnology, Health Care
Compare BIOMES vs Realize Therapeutics
BIOMES vs
DayTwo
DayTwo United States

Precision Nutrition for Metabolic Disease

Unknown
16 employees
Biotechnology, Health Care
Compare BIOMES vs DayTwo
BIOMES vs
Moss Genomics
Moss Genomics

Moss offers personalized health, anti-aging and wellness offerings guided by genomic, microbiome, an...

2 employees
AI, Biotechnology
Also compare with: BIOMES vs BIOME9 BIOME9 View all alternatives

FAQ About BIOMES

Health prevention based on genomics: because well-being is encoded in our DNA.
BIOMES was founded in 2017.
BIOMES is headquartered in Wildau, Germany.
BIOMES has approximately 37 employees.
BIOMES has completed 4 funding rounds, raising a total of $4.00M. The latest funding stage is Unknown.
BIOMES offers: Microbiome analysis and personalized nutrition recommendations.
Top alternatives and competitors to BIOMES include Realize Therapeutics, DayTwo, Moss Genomics, BIOME9, AMILI . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIOMES and Realize Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BIOMES and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy